EFPIA Welcomes EMA’s Electronic Format Plan For Package Leaflets But Not ‘Key Info’ Idea
Executive Summary
The EMA has published an action plan on improving the product information companies provide in package leaflets and the SmPC.
You may also be interested in...
EU Looks To eFormats To Improve Accessibility Of Medicines Info
The idea of improving the readability of information in medicine package leaflets using electronic formats is being discussed at EU level, with a multi-stakeholder workshop to be held later this year.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.